Also found in: Dictionary.

candesartan cilexetil

Amias (UK), Atacand

Pharmacologic class: Angiotensin II receptor antagonist

Therapeutic class: Antihypertensive

Pregnancy risk category D

FDA Box Warning

• When used during second or third trimester of pregnancy, drug may cause fetal injury and death. Discontinue as soon as possible when pregnancy is detected.


Blocks aldosterone-producing and vasoconstrictive effects of angiotensin II at various receptor sites, including vascular smooth muscle and adrenal glands


Tablets: 4 mg, 8 mg, 16 mg, 32 mg

Indications and dosages


Adults: 16 mg P.O. daily. Start at lower dosage if patient is receiving diuretics or is volume depleted. Range is 8 to 32 mg/day as a single dose or divided in two doses.

Children age 6 to younger than 17 weighing more than 50 kg (110 lb): 8 to 16 mg P.O. daily. Start at lower dosage if patient is receiving diuretics or is volume depleted. Range is 4 to 32 mg/day as a single dose or divided in two doses.

Children age 6 to younger than 17 weighing less than 50 kg: 4 to 8 mg P.O. daily. Start at lower dosage if patient is receiving diuretics or is volume depleted. Range is 4 to 16 mg/day as a single dose or divided in two doses.

Children age 1 to younger than 6: 0.20 mg/kg oral suspension P.O. daily. Start at lower dosage if patient is receiving diuretics or is volume depleted. Range is 0.05 to 0.4 mg/kg oral suspension P.O. daily as a single dose or divided in two doses.

Heart failure (New York Heart Association class II-IV)

Adults: 4-mg tablet P.O. daily. Increase to target maintenance dosage of 32 mg P.O. daily by doubling dose q 2 weeks, as tolerated.

Dosage adjustment

• Renal impairment

• Moderate hepatic insufficiency


• Hypersensitivity to drug or its components


Use cautiously in:

• heart failure, renal or hepatic impairment

• volume- or salt-depleted patients receiving high doses of diuretics, hyperkalemia

• pregnant or breastfeeding patients

• children younger than age 1.


• Give with or without food.

• Be aware that pharmacist can prepare a suspension from tablets for children who can't swallow tablets.

Supervise patient closely if he is receiving concurrent diuretics or is otherwise at risk for intravascular volume depletion.

• Know that diuretic may be added to regimen if candesartan alone doesn't control blood pressure.

Adverse reactions

CNS: dizziness, syncope, fatigue, headache

CV: hypotension, chest pain, peripheral edema, mitral or aortic valve stenosis

EENT: ear congestion or pain, sinus disorders, sore throat

GI: nausea, diarrhea, constipation, abdominal pain, dry mouth

GU: albuminuria, renal failure

Hepatic: hepatitis

Metabolic: gout, hyperkalemia

Musculoskeletal: arthralgia, back pain, muscle weakness

Respiratory: upper respiratory tract infection, cough, bronchitis

Other: dental pain, fever


Drug-drug. Diuretics, other antihypertensives: increased risk of hypotension

Lithium: increased lithium blood level

Nonsteroidal anti-inflammatory drugs: decreased antihypertensive effect

Potassium-sparing diuretics, potassium supplements: increased risk of hyperkalemia

Drug-food. Salt substitutes containing potassium: increased risk of hyperkalemia

Drug-herbs. Ephedra (ma huang), licorice, yohimbine: decreased antihypertensive effect

Patient monitoring

• Monitor electrolyte levels and kidney and liver function test results.

• Assess blood pressure regularly to gauge drug efficacy.

• Closely monitor patient with renal dysfunction who is receiving concurrent diuretics.

Patient teaching

• Tell patient to take drug with or without food.

• Inform caregiver that pharmacist will prepare a suspension for child who can't swallow tablets. Shake suspension well before each dose.

• Teach patient about lifestyle changes that help control blood pressure, such as proper diet, exercise, stress reduction, smoking cessation, and moderation of alcohol intake.

• Instruct patient to use reliable birth control method and to contact prescriber and discontinue drug if she suspects she's pregnant.

• Caution patient not to take herbs without consulting prescriber.

• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, foods, and herbs mentioned above.

McGraw-Hill Nurse's Drug Handbook, 7th Ed. Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved


A trademark for the drug candesartan cilexetil.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.


An antihypertensive angiotensin-II-receptor blocker.
Adverse events
Upper respiratory tract infection, dizziness, back pain.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.


Candasartan cilexitil Cardiology An angiotensin II receptor blocker used alone or with other agents for HTN. See ABC, CANDLE.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Royalty and other decreased 91% to $0.4 million from $4.9 million, primarily due to the launches of Atacand, Atacand HCT, Arimidex, and Casodex under the ANI label in the second half of 2018.
Arthur S Przybyl, ANI's president and CEO, said, 'We are pleased to announce the launch of the authorized generic of our brand product Atacand HCT.
AstraZeneca Plc (LSE:AZ), a global, science-led biopharmaceutical company, announced on Monday the completion of an agreement with Cheplapharm Arzneimittel GmbH (Cheplapharm) for the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) for 28 countries in Europe.
AstraZeneca plans to continue to market and supply ATACAND, ATACAND HCT, ARIMIDEX and CASODEX outside of the US.
But the hypertension market growth will be countered by significant drug patent expirations both prior to and during the forecast period, including those of Cozaar in 2010, Diovan, Avapro and Atacand in 2012, Exforge in 2014, Benicar in 2016, and Tekturna and Tekturna HCT in 2018.
- Atacand (Chronic Heart Failure) - Forecast and Market Analysis to 2022
Some commonly prescribed drugs in this class are candesartan (Atacand), eprosartan (Teveten), irbesarten (Avapro), losartan (Cozaar), telmisartan (Micardis) and valsartan (Diovan).
Much of the damage was caused by loss of exclusivity on antipsychotic medicine Seroquel and heart drug Atacand in many markets.
Such a move holds the promise of giving consumers access to chronic-condition drugs such as Avapro, Diovan and Atacand for hypertension; Lescol and Tricor for hyperlipidemia; Maxalt and Zomig for migraine; and Singulair and Xopenex for asthma.
There are seven single-ingredient ARBs approved by the FDA for treating hypertension: candesartan (Atacand), irbesartan (Avapro), olmesartan (Benicar), losartan (Cozaar), valsartan (Diovan), telmisartan (Micardis), and eprosartan (Teveten).
These drugs include Cozaar, Benicar, and Atacand. If it is, there may be another more natural solution.
sales of several AstraZeneca medicines, including heart drugs Atacand and Plendil.